Clinical Trial Update: SCLC Tarlatamab Blood Collection

View source ↗

Summary

Duke University is conducting a small-cell lung cancer trial of tarlatamab, which is currently not yet recruiting and involves blood collection activities.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Tarlatamab

Snippet

Sponsor: Duke University | Conditions: Small-cell Lung Cancer | Status: NOT_YET_RECRUITING